Document is current
Any future updates will be listed below
-
Authors
Gaynor, Sheila M. https://orcid.org/0000-0002-7869-5223
Joseph, Tyler
Bai, Xiaodong
Zou, Yuxin
Boutkov, Boris
Maxwell, Evan K. https://orcid.org/0000-0002-7325-7531
Delaneau, Olivier https://orcid.org/0000-0002-3906-8446
Hofmeister, Robin J.
Krasheninina, Olga
Balasubramanian, Suganthi https://orcid.org/0000-0003-2243-5948
Marcketta, Anthony
Backman, Joshua https://orcid.org/0000-0001-7262-0880
,
Reid, Jeffrey G. https://orcid.org/0000-0001-8645-4713
Overton, John D.
Lotta, Luca A. https://orcid.org/0000-0002-2619-5956
Marchini, Jonathan https://orcid.org/0000-0003-0610-8322
Salerno, William J. https://orcid.org/0000-0003-2975-4108
Baras, Aris https://orcid.org/0000-0002-6830-3396
Abecasis, Goncalo R. https://orcid.org/0000-0003-1509-1825
Thornton, Timothy A. https://orcid.org/0000-0001-7071-2642
-
Funding
Funding for this research was provided by:
Regeneron Genetics Center
- License Information
-
More Information
Article History
Received: 5 September 2023
Accepted: 23 August 2024
First Online: 25 September 2024
Competing interests
: S.M.G., T.J., X.B., Y.Z., B.B., E.K.M., O.D., O.K., S.B., A.M., J.B., J.G.R., J.D.O., L.A.L., J.M., W.J.S., A.B., G.R.A. and T.A.T. are current employees and/or stockholders of Regeneron Genetics Center or Regeneron Pharmaceuticals. The other authors declare no competing interests.
